Evotec Competitors and Similar CompaniesClear all
Eurofins's competitors and similar companies include WuXi Biologics and Catalent.
 WuXi Biologics WuXi Biologics (药明生物) is a company operating as an open-access technology platform for biologics drug development. |  Catalent Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products. | ||
Founding Date | Founding Date 1987 | Founding Date 2010 | Founding Date 2007 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Wuxi, CN HQ George Town, KY Wuppertal, DE Hong Kong, HK Dundalk, IE Cranbury, US King Of Prussia, US | Locations Bridgewater, US HQ Buenos Aires, AR Bruxelles, BE Charleroi, BE Charleroi, BE Charleroi, BE Indaiatuba, BR see more | |
Employees | Employees 65,694 | Employees 12,575 | Employees 12,6955% increase |
Financial | |||
Revenue (est.) | Revenue (est.) €7.3b (FY, 2025) | Revenue (est.) ¥21.8b (FY, 2025) | Revenue (est.) $4.4b (FY, 2024) |
Cost of goods | Cost of goods €2.3b (FY, 2025) | Cost of goods ¥10b (FY, 2025) | Cost of goods $3.4b (FY, 2024) |
Gross profit | Gross profit €5b (FY, 2025) | Gross profit ¥12b (FY, 2025) | Gross profit $953m (FY, 2024) |
Net income | Net income €473m (FY, 2025) | Net income ¥5.7b (FY, 2025) | Net income ($1b) (FY, 2024) |
Operating ⚠ | |||
Backlog | Backlog N/A | Backlog $18.5b (H1, 2022) | Backlog $2.5b (FY, 2023) |
Countries | Countries 62 (FY, 2023) | Countries N/A | Countries 80 (FY, 2023) |
Funding | |||
Total funding raised | Total funding raised $ 30m | Total funding raised N/A | Total funding raised $ 650m |
For sources of this data, please see the company profile
View Company Profiles
WuXi Biologics
HQ
Wuxi, CN
Employees
12,575
WuXi Biologics (药明生物) is a company operating as an open-access technology platform for biologics drug development.
View companyCatalent
HQ
Bridgewater, US
Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products.
View company